MFDS — authorised 25 March 2020
- Marketing authorisation holder: CELGENE INTL
- Status: likely_approved
🇰🇷 Zeposia in South Korea
MFDS authorised Zeposia on 25 March 2020
Marketing authorisation
Zeposia in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Zeposia approved in South Korea?
Yes. MFDS authorised it on 25 March 2020.
Who is the marketing authorisation holder for Zeposia in South Korea?
CELGENE INTL holds the South Korean marketing authorisation.